Cargando…
Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers
An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management. NAS exhibited potent broadly neutralizing activities against SARS-CoV-2 with PVNT(50) values ranging from 0.0035 to 3.1997 μg/ml for t...
Ejemplares similares
-
Development and Evaluation of Novel Water-Based Drug-in-Adhesive Patches for the Transdermal Delivery of Ketoprofen
por: Arunprasert, Kwanputtha, et al.
Publicado: (2021) -
Complete Genome Sequence of a Zika Virus Strain Isolated from the Serum of an Infected Patient in Thailand in 2006
por: Nitatpattana, Narong, et al.
Publicado: (2018) -
Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development
por: Phakham, Tanapati, et al.
Publicado: (2022) -
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss after Failure from Oral and Intratympanic Corticosteroid
por: Imsuwansri, Thanarath, et al.
Publicado: (2012) -
Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants
por: Boonkrai, Chatikorn, et al.
Publicado: (2023)